Results 61 to 70 of about 5,078 (164)

Leukocytoclastic Vasculitis [PDF]

open access: yesEffective Pharmacotherapy, 2019
E.V. Dvoryankova   +3 more
openaire   +2 more sources

Cutaneous Vasculitis and Recurrent Infection Caused by Deficiency in Complement Factor I

open access: yesFrontiers in Immunology, 2018
Cutaneous leukocytoclastic vasculitis arises from immune complex deposition and dysregulated complement activation in small blood vessels. There are many causes, including dysregulated host response to infection, drug reactions, and various autoimmune ...
Sira Nanthapisal   +9 more
doaj   +1 more source

Apixaban as a Rare Cause of Leukocytoclastic Vasculitis

open access: yesCase Reports in Rheumatology, 2020
Apixaban is a rare cause of leukocytoclastic vasculitis (LCV). To our knowledge, there is only one other reported case due to apixaban in the literature. We present a case of apixaban-induced leukocytoclastic vasculitis in a 95-year-old male. He had been
Jenna Spears   +4 more
doaj   +1 more source

From Nerves to Vessels: Unmasking Churg‐Strauss Behind Polyneuropathy

open access: yesClinical Case Reports, Volume 14, Issue 5, May 2026.
ABSTRACT Eosinophilic granulomatosis with polyangiitis (EGPA), formerly Churg‐Strauss vasculitis, is a rare systemic autoimmune disease. Neurological involvement is a significant complication. This report details a case of EGPA with severe, progressive polyneuropathy and atypical serological findings, highlighting diagnostic challenges and the ...
Hiba Antar   +2 more
wiley   +1 more source

Leukocytoclastic Vasculitis as a Complication of Recombinant Granulocyte Colony-Stimulating Factor Therapy in a Heart Transplant Patient

open access: yesCase Reports in Transplantation, 2014
Recombinant granulocyte colony-stimulating factor (rG-CSF) is a myeloid growth factor that is widely used in haematology to recover neutropenia secondary to myelosuppressive chemotherapy.
Giovanbattista Ippoliti   +4 more
doaj   +1 more source

A Multifaceted Holistic Review of the Literature on Scar Dermatoses

open access: yesInternational Wound Journal, Volume 23, Issue 5, May 2026.
ABSTRACT Many cutaneous diseases originate or manifest in scars. Scars are areas of compromised skin, which renders them a vulnerable cutaneous district for diseases to develop. The pathophysiology explaining why some dermatoses grow in scars is not yet thoroughly explored. The present study reviews the present literature on scar dermatoses.
Dana Maria Khoury   +5 more
wiley   +1 more source

Novel Clinical and Histological Insights into Cutaneous Kikuchi‐Fujimoto Disease and Kikuchi Disease‐Like Inflammatory Pattern (KLIP)

open access: yes
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 7, Page e983-e987, July 2026.
Magí Brufau‐Cochs   +7 more
wiley   +1 more source

Cutaneous polyarteritis nodosa: A rare isolated cutaneous vasculitis

open access: yesIndian Dermatology Online Journal, 2012
Cutaneous polyarteritis nodosa (CPAN) is a rare form of cutaneous vasculitis that involves small and medium sized arteries of the dermis and subcutaneous tissue without systemic involvement. It presents with tender subcutaneous nodules, digital gangrene,
Praveen Kumar A Subbanna   +2 more
doaj   +1 more source

The GLP‐1 Receptor Agonist Paradox in Dermatology: Why We Cannot Afford the Knowledge Gap

open access: yes
International Journal of Dermatology, Volume 65, Issue 7, Page 1361-1362, July 2026.
Ramy Awadalla, Derek Davies
wiley   +1 more source

A Case of Methimazole Induced Leukocytoclastic Vasculitis

open access: yesEndocrinology Research and Practice, 2005
Antineutrophilic cytoplasmic antibody (ANCA)-associated vasculitis has been described frequently in patients treated with propylthiouracil (PTU). However, other antithyroid drugs, carbimazole and methimazole (MMI), rarely cause vasculitis.
Mustafa Kanat   +2 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy